Kiniksa Pharmaceuticals Stock Forecast - 8 Period Moving Average
| KNSA Stock | USD 21.17 0.68 3.11% |
The 8 Period Moving Average forecasted value of Kiniksa Pharmaceuticals on the next trading day is expected to be 21.71 with a mean absolute deviation of 0.97 and the sum of the absolute errors of 51.16. Kiniksa Stock Forecast is based on your current time horizon. Investors can use this forecasting interface to forecast Kiniksa Pharmaceuticals stock prices and determine the direction of Kiniksa Pharmaceuticals's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Kiniksa Pharmaceuticals' historical fundamentals, such as revenue growth or operating cash flow patterns.
Kiniksa |
Kiniksa Pharmaceuticals 8 Period Moving Average Price Forecast For the 5th of December
Given 90 days horizon, the 8 Period Moving Average forecasted value of Kiniksa Pharmaceuticals on the next trading day is expected to be 21.71 with a mean absolute deviation of 0.97, mean absolute percentage error of 1.80, and the sum of the absolute errors of 51.16.Please note that although there have been many attempts to predict Kiniksa Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kiniksa Pharmaceuticals' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Kiniksa Pharmaceuticals Stock Forecast Pattern
| Backtest Kiniksa Pharmaceuticals | Kiniksa Pharmaceuticals Price Prediction | Buy or Sell Advice |
Kiniksa Pharmaceuticals Forecasted Value
In the context of forecasting Kiniksa Pharmaceuticals' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kiniksa Pharmaceuticals' downside and upside margins for the forecasting period are 18.80 and 24.63, respectively. We have considered Kiniksa Pharmaceuticals' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the 8 Period Moving Average forecasting method's relative quality and the estimations of the prediction error of Kiniksa Pharmaceuticals stock data series using in forecasting. Note that when a statistical model is used to represent Kiniksa Pharmaceuticals stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 103.9931 |
| Bias | Arithmetic mean of the errors | 0.3137 |
| MAD | Mean absolute deviation | 0.9653 |
| MAPE | Mean absolute percentage error | 0.0413 |
| SAE | Sum of the absolute errors | 51.1625 |
Predictive Modules for Kiniksa Pharmaceuticals
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kiniksa Pharmaceuticals. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kiniksa Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Other Forecasting Options for Kiniksa Pharmaceuticals
For every potential investor in Kiniksa, whether a beginner or expert, Kiniksa Pharmaceuticals' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kiniksa Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kiniksa. Basic forecasting techniques help filter out the noise by identifying Kiniksa Pharmaceuticals' price trends.View Kiniksa Pharmaceuticals Related Equities
| Risk & Return | Correlation |
Kiniksa Pharmaceuticals Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Kiniksa Pharmaceuticals' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Kiniksa Pharmaceuticals' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kiniksa Pharmaceuticals Market Strength Events
Market strength indicators help investors to evaluate how Kiniksa Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kiniksa Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Kiniksa Pharmaceuticals stock market strength indicators, traders can identify Kiniksa Pharmaceuticals entry and exit signals to maximize returns.
Kiniksa Pharmaceuticals Risk Indicators
The analysis of Kiniksa Pharmaceuticals' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kiniksa Pharmaceuticals' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kiniksa stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.97 | |||
| Standard Deviation | 2.89 | |||
| Variance | 8.38 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Kiniksa Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kiniksa Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kiniksa Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kiniksa Pharmaceuticals Stock:Check out Historical Fundamental Analysis of Kiniksa Pharmaceuticals to cross-verify your projections. For information on how to trade Kiniksa Stock refer to our How to Trade Kiniksa Stock guide.You can also try the Volatility Analysis module to get historical volatility and risk analysis based on latest market data.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kiniksa Pharmaceuticals. If investors know Kiniksa will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kiniksa Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 5.5 | Earnings Share (0.12) | Revenue Per Share 5.415 | Quarterly Revenue Growth 0.674 | Return On Assets (0.03) |
The market value of Kiniksa Pharmaceuticals is measured differently than its book value, which is the value of Kiniksa that is recorded on the company's balance sheet. Investors also form their own opinion of Kiniksa Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Kiniksa Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kiniksa Pharmaceuticals' market value can be influenced by many factors that don't directly affect Kiniksa Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kiniksa Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Kiniksa Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kiniksa Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.